The intestinal epithelium maintains homeostasis by a self-renewal process involving resident stem cells, including Lgr5 þ crypt-base columnar cells, but core mechanisms and their contributions to intestinal cancer are not fully defined. In this study, we examined a hypothesized role for KLF5, a zinc-finger transcription factor that is critical to maintain the integrity of embryonic and induced pluripotent stem cells, in intestinal stem-cell integrity and cancer in the mouse. Klf5 was indispensable for the integrity and oncogenic transformation of intestinal stem cells. In mice, inducible deletion of Klf5 in Lgr5 þ stem cells suppressed their proliferation and survival in a manner associated with nuclear localization of b-catenin (Catnb), generating abnormal apoptotic cells in intestinal crypts. Moreover, production of lethal adenomas and carcinomas by specific expression of an oncogenic mutant of b-catenin in Lgr5 þ stem cells was suppressed completely by Klf5 deletion in the same cells. Given that activation of the Wnt/b-catenin pathway is the most frequently altered pathway in human colorectal cancer, our results argue that KLF5 acts as a fundamental core regulator of intestinal oncogenesis at the stem-cell level, and they suggest KLF5 targeting as a rational strategy to eradicate stem-like cells in colorectal cancer. Cancer Res; 74(10); 2882-91. Ó2014 AACR.
Introduction
The intestinal epithelium is maintained by a self-renewal in the crypts. In this process, the resident stem cells located in the crypt base produce proliferating progenitors, transit-amplifying cells, which move upward as coherent columns (1, 2) . Intestinal epithelia include short-lived progenitors, long-lived progenitors, columnar cell progenitors, and pluripotential stem cells (3) . The stem-cell pools include Lgr5 þ crypt-base columnar (CBC) cells and Lrig1 þ cells at the bases of crypts, and Hopx þ or Bmi1 þ cells located at the þ4 position from the bottom of the crypts (1, (4) (5) (6) (7) (8) . Lgr5 þ cells constitute intestinal stem cells under normal condition (4, 9) . When Lgr5 þ cells are specifically deleted in small intestine, Bmi-1 þ cells compensate for Lgr5 þ stem cells and crypts can be maintained (10) . These "þ4 cells" may be the quiescent Paneth cell precursors that can revert back into Lgr5 þ stem cells following crypt damage (11) .
These indicate plasticity of intestinal stem cells. Intestinal stem cells also show differential stem-cell activation with damage (12) (13) (14) . The stem cells are maintained by the descendants of dominantly surviving stem cells in a crypt, under "neutral competition" between equipotent stem cells. This maintenance pattern is repeated to sustain the stem cells. The stem-cell survival is supported by stem-cell niche, including Paneth cells (2, 15) .
Intestinal stem cells are also the focus on attention in the context of oncogenesis. Inducible deletion of the tumor-suppressor gene adenomatous polyposis coli (Apc) in the Lgr5 þ CBC stem cells of the mice gives rise to more tumors than deletion of Apc in more differentiated, nonstem cells (16) . It has also been shown that in mice Lgr5 þ CBC cells constitute a subpopulation of adenoma cells that fuel the growth of established adenomas and function as cancer stem cells (CSC; ref. 17) . We have recently established cancer cell lines from the samples of human colorectal cancers that express Lgr5 and possess CSC properties (18) . These Lgr5 þ colonic CSCs, interconvert with drug-resistant Lgr5 À cells after drug treatment and are capable of tumor reconstitution. Thus, these observations lend support to the notion that oncogenic changes at the stem-cell stage are more critical than those in the differentiated nonstem stages during oncogenesis (19) . A comprehensive genome-sequencing analysis has elucidated several altered genes and pathways in colorectal cancer, including the Wnt/b-catenin (Catnb), Ras-MAPK, PI3K, TGF-b, p53, and DNA mismatch-repair pathways (20) . However, despite much attention to intestinal stem cells in the context of homeostasis and oncogenesis in the intestine, the mechanisms underlying the genetic pathways of cellular differentiation as well as those responsible for colorectal cancer development remain poorly understood.
In this study, we focused on the transcription factor, Kr€ uppel-like factor 5 (KLF5), a zinc-finger transcription factor of the KLF family, which carries versatile functions in the homeostasis and pathogenesis of multiple systems, including the cardiovascular, metabolic, and renal (21) . Intriguingly, KLF5 controls the stemness of embryonic stem (ES) cells (22) and has the potential to generate induced pluripotent stem (iPS) cells, albeit more weakly than KLF4 (23) . Moreover, KLF2, KLF4, and KLF5 cooperatively constitute transcriptional autofeedback loops along with other iPS cell-inducing factors to sustain the stemness in ES cells (24) . In contrast, the functions of KLF5 in adult somatic stem-cell regulations have remained to be elucidated. In the normal intestines, KLF5 is expressed in a polarized pattern: at higher levels in crypts in which stem cells reside, and lower levels in villi in which differentiated cells reside (21, 25) . In contrast, KLF4 is expressed in a pattern complementary to that of KLF5 (26) . Of further note, Klf5 þ/À mice have shorter and less mature villi than Klf5 þ/þ mice (27) , and noninducible and congenital deletion of KLF5 in all intestinal epithelia through all developmental stages (Villin Cre Klf5 flox/flox mice) resulted in the severe morphologic changes of intestine (28) . On the basis of these observations, we hypothesized that KLF5, rather than KLF4, governed homeostasis and oncogenesis in stem and transitamplifying cells of the intestinal epithelia. The functions of KLF5 in adult somatic stem-cell regulations, including oncogenesis, have remained to be clarified. The previous congenital deletions of Klf5 showed the functions of KLF5 in the intestinal development, but did not demonstrate those in the homeostatic turnover of the fully developed intestinal epithelia from the stem cells. As such, we constructed a stem-cell-specific and tamoxifen-inducible deletion system for Klf5 in mice. Furthermore, we used a novel system in which oncogenic activation of Wnt/Catnb signaling and deletion of Klf5 could be induced simultaneously specifically in the intestinal stem cells.
Materials and Methods
Additional Materials and Methods are available as Supplementary Materials and Methods.
Mice
The mouse transgenics used were as follows: Lgr5-EGFPires-CreERT2 (4), Klf5 flox/flox (29) , and Catnb lox(Dex3) (30) . All strains were backcrossed with C57BL/J background mice. Genotyping was performed by PCR, using genomic DNA purified from the tail, as described previously (4, 29, 30) .
Induction of activated Cre recombinase
To induce the activation of Cre recombinase and genomic recombination at flox sites, mice were given daily intraperitoneal injections of 200 mL of tamoxifen (Sigma-Aldrich; 10 mg/mL) dissolved in sunflower oil, for 3 to 10 days.
Tissue isolation and histopathology
Small intestines were removed immediately from sacrificed mice, opened, washed with 1Â PBS, fixed overnight in 10% neutral-buffered formalin, and embedded in paraffin. Immunohistochemical/immunofluorescence staining (detailed methods are described in Supplementary Materials and Methods) and hematoxylin-eosin (H&E) staining were performed on the paraffin slides of the mice intestines or the surgical specimens of human colorectal cancers, fixed in neutral-buffered formalin.
Isolation of intestinal stem cells and transit-amplifying cells from Lgr5-EGFP-ires-CreERT2 mice
Intestinal crypts were isolated from the duodenum and jejunum (3-4 cm in length from the pylorus) from Lgr5-EGFP-ires-CreERT2 mice. The GFP þþ stem and GFP þ transit-amplifying cells were sorted from the trypsinized epithelial cells by FACSAria (Becton Dickinson). The total RNAs from these cells were extracted and subjected to the microarrays (Agilent) or cDNA preparations for real-time PCR (RT-PCR) analysis. The detailed methods are described in Supplementary Materials and Methods.
Results

KLF5 in homeostatic maintenance and proliferation of intestinal epithelial stem cells
We first examined the function of Klf5 in normal homeostasis and turnover of stem-cell-derived intestinal epithelia in mice with a stem-cell-specific deletion of Klf5 that were generated by crossing Lgr5-EGFP-ires-CreERT2 and Klf5 flox/flox mice (4, 29) . Because Cre-ERT2 fusion gene activity is inducible following tamoxifen administration, this experimental system has the advantage of being able to analyze the specific function of Klf5 in the intestinal epithelial stem cells, thereby avoiding artifacts that might arise from deficiency of Klf5 throughout development (4, 28) . As shown in Fig. 1 Tables S7-S14 ).
This may lend support to the notion that the Klf5 and Wnt/ Catnb pathways are interconnected in the context of the regulation of the intestinal stem cells.
Expression status of KLF5 and genome amplifications at KLF5 locus in human colorectal cancers In addition to the role of KLF5 in lineage reprogramming and stemness acquisition, there has been much attention focused on its role in oncogenesis (21) . Noncancerous tissue from patients with colorectal cancer exhibited polarized expression patterns of KLF5 in which expression was found to be stronger in the bottoms of crypts where the stem and transit-amplifying cells reside, and weaker as epithelial cells differentiated (Fig. 5A, left) . On the other hand, KLF5 was expressed more strongly in cancer epithelia than in normal epithelia, both in colorectal mucosa and in liver metastases. Indeed, we found these colorectal cancer cells lost their polarity of KLF5 expression ( Fig. 5A and D-G, right). Gastric cancers also had stronger expressions of KLF5 than the noncancerous epithelia (Fig. 5H-J) .
Here, we performed an analysis of genome copy-number changes in human cancer tissues by array comparative genomic hybridization (CGH; ref. 33 ). The genes mapped in frequently genome-amplified regions in cancers often possess oncogenic and/or tumor-promoting functions. We revealed that focal genome amplifications, including the KLF5 locus, were accumulated in human colorectal cancer and gastric cancers (Fig. 5B) . Furthermore, we observed frequent chromosomal amplification of the 13q region, the location where the KLF5 gene is mapped, in colorectal cancer (Fig. 5C ). Thus, these data suggested that KLF5 is a candidate oncogene for intestinal tumors, acting at the level of the stem-cell homeostasis (20, 34) . Fig. S3A ; ref.
30). Briefly, we observed that the Lgr5-EGFP-ires-CreERT2/ Catnb lox(Dex3) /Klf5 þ/þ strain allowed Lgr5 þ stem-cell-specific induction of an active Catnb mutant that is resistant to proteolysis, which caused the formation of severe adenomas and carcinomas (Fig. 6A , B and D and Supplementary Fig. S3B ). Indeed, more than 70% of these mice died within 49 days due to the enlargement of lethal adenomas or carcinomas (Fig. 6F) . Interestingly, this phenotype was found to be completely (Fig. 6F) . Some microadenomas were detected in the Lgr5-EGFP-iresCreERT2 Catnb lox(Dex3) Klf5 flox/flox mice after Cre recombinase induction ( Fig. 6C and E) . Because the microadenoma cells in the Lgr5-EGFP-ires-CreERT2 Catnb lox(Dex3) Klf5 flox/flox mice expressed Klf5 (Fig. 6E) , we speculate that these microadenomas were caused by insufficient deletion of Klf5 by Cre recombinase in cells expressing the active mutant of Catnb. In view of the fact that alterations in the Wnt/Catnb pathway are the most frequently mutated in tumors, 92% to 97% of tumors affected in colorectal cancer according to one report (20) , these results indicate that the Klf5-Wnt/Catnb axis in the stem cells is essential for the oncogenesis of most intestinal tumors. Tables S1-S6 , S13-S16; ref. 32) . We found that the simultaneous deletion of Klf5 under the induction of the active mutant of Catnb suppressed the transcription of Hdac1, which promotes colorectal cancer, in both stem and transit-amplifying cells ( Fig. 7A ; Supplementary Table S5; ref. 35 ). The tumor-suppressive microRNAs (miRNA) miR-451, miR-193b, miR-125a-5p, let7d, and let-7e were upregulated upon deletion of Klf5; in contrast, miR-18a, which is expressed at higher levels in colorectal cancer, was downregulated (Supplementary Tables  S15-S16 ). These transcriptional changes related to oncogenesis may explain the almost complete suppression of oncogenesis when Klf5 is deleted simultaneously to the induction of the active mutant of Catnb.
Discussion
In the present study, we investigated the role of KLF5 in the homeostatic regulation of intestinal stem cells and in oncogenesis induced by the Wnt/Catnb axis. KLF5 is strongly expressed in epithelial cells at the base of the crypts of the intestine, but not in the differentiated epithelial cells in the villi, suggesting the potential of KLF5 to control intestinal stem cells and immature epithelial cells, including transit-amplifying cells (21, 25) . Our results using mice with a stem-cell-specific inducible deletion of Klf5 indicate that Klf5 positively controls the proliferation and survival of the intestinal stem cells as well as transit-amplifying cells (Figs. 1-3) .
It has been shown that in ES cells, KLF5 collaborates with KLF4, Sox2, Oct4, and other iPS cell-generating factors in an autofeedback loop that maintains stemness (24) . In contrast, in intestinal epithelial cells, KLF5, rather than KLF4, is essential for stem-cell control as shown in our study.
It has been reported previously that an inducible deletion of Oct4, another iPS cell-generating factor, does not affect the homeostasis of intestinal epithelia, although the induction of Oct4 causes dysplasia in intestinal epithelia (36, 37) . It will be interesting to investigate gene regulatory networks aimed at revealing the similarities and differences between the stemness control mechanisms of somatic intestinal epithelial stem cells by KLF5 and these transcription factors.
Of note, we found the increase in the number of apoptotic cells upon the inducible deletion of Klf5 in the Lgr5 þ stem cells (Fig. 1) . It has been reported that KLF5 has an antiapoptotic function by inducing the expression of survivin, a factor making cells resistant to apoptosis, and that KLF5 binds to the promoter of the survivin gene and interacts with p53 to interfere with its function (38) . Thus, although further work will be required, it is possible that the KLF5-survivin pathway may be critical to the survival of the intestinal stem cells.
The stem cells and transit-amplifying cells have the deviations of original intracellular conditions among them. We speculate that's why inducible deletion of Klf5 caused apoptosis only in the restricted population of stem and transitamplifying cells, which were originally prone to apoptosis (Fig.  1) . This speculation is consistent with "neutral competitions of equipotent stem cells," in which slightly strong stem cells for survival can leave their offspring as stem cells, defeating other stem cells (2, 15) . The decrease of Klf5-deleted stem cells also supports this speculation (Fig. 2C) .
There has been accumulating reports showing abnormal expression of KLF5 in many cancer types, though its function therein is still controversial. The expression of KLF5 mRNA is frequently reduced or absent in cancerous cells, including those of intestinal tumors and adenomatous polyposis adenomas (39) . In contrast, the congenital haploinsufficiency of Klf5 reduced the intestinal tumor of congenital Apc min mice (40) . The expression of KLF5 mRNA is also increased in breast cancer (41) . Thus, KLF5 may have context-dependent functions in oncogenesis.
Our inducible and stem-cell-specific gene alteration system triggers Wnt/Catnb signal activation by the induction of active mutant of Catnb. Most of Wnt/Catnb signal activation in human colorectal cancer is caused by the loss or mutation of Apc, and Catnb is rarely mutated in human colorectal cancer (20) . Apc has other functions besides regulating nuclear Catnb and different mutations in Apc have different strengths (42) . Furthermore, Lgr5-Cre needs to remove both Apc alleles to cause adenomas, whereas other drivers like the Lrig-1 Cre only needs to remove one allele of Apc to induce tumor formation, because the second allele is lost by loss of heterozygosity in this situation (8, 16 ). These observations show potential differences in the ability of the cells to form tumors in different contexts.
In addition to these, human colorectal cancer are developed by the accumulation of genetic changes. Thus, our experimental system is not a perfect simulation of human colorectal cancer. However, our experimental system has the advantage to be much more similar to the sporadic genome changes in the stem cells, which actually occur in the oncogenesis of most
Ch19 Ch20 Ch21 Ch22 human colorectal cancer, than the previous congenital, noninducible, and nonstem-cell-specific gene alteration systems (16, 40) . In our present study, we have given the clear answer to the previous controversial discussions (Fig. 6 ).
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This finding is interesting because it has been reported that KLF5 is a target gene of Wnt-1 signaling linked to a protein kinase C pathway, but not to the Catnb-Lef/T-cell factor pathway (43, 44) . Although further work will be required to clarify the complex network of the KLF5 and Wnt/Catnb pathways, these pathways may contribute to the enhancement of the proliferative and oncogenic pathways in the intestinal stem cells. In Ah Cre mice, Myc deletion was reported to rescue Apc deficiency in the intestine (45) . In our system, Klf5 deletion rescued the phenotype of abnormal Catnb activation, which is biologically similar to that of Apc deficiency. Regulatory network of stemness in ES cells, revealed by combining proteinproteins and protein-DNA interactions, is composed of three modules (core module, including KLF5/4, polycomb module, and Myc module). The Myc module, independent of the core module, is active in acute myeloid leukemias, bladder cancers, and breast cancers, and its activity predicts cancer outcome (46) . Here, our study indicates that the Core module is fundamentally important for the oncogenesis of intestines.
We investigated the mRNA and miRNA expression changes of the FACS-sorted stem cells and transit-amplifying cells in Fig. 5D and E), implying that KLF5 has essential functions not only in the oncogenesis of colorectal cancer, but also in the maintenance of the tumor even after metastasis. Knockdown of KLF5 in human colorectal cancer cell lines suppresses cell growth (47) , which is consistent with our results. These findings underscore the role of KLF5 as a fundamental regulator of intestinal stem cells in homeostatic and neoplastic proliferation. Currently, monoclonal antibody against EGFR and VEGF are used for colorectal cancer therapy in conjunction with chemical drugs, fluorouracil, and oxaliplatin. However, most colorectal cancer depend on Wnt/Catnb signaling, whereas EGFR represents an alternative pathway (20) . Therefore, blocking EGFR pathways may be insufficient to cure colorectal cancers. Intestinal tumors are generated mainly from stem cells, and are maintained by dedicated and slow-growing stem cells (16) (17) (18) . Because anticancer drugs attack proliferating cells, they are not effective against slowly growing cells. Therefore, for colorectal cancer therapy to be optimally effective, interventions will be required to target the slowly growing CSCs. In line with this, it was shown that nanoparticle delivery of siRNA for suppressing KLF5 in transplanted lung carcinomas reduced the tumor size in mice (48) . Thus, our present findings on the critical role of KLF5 in the oncogenic transformation of intestinal stem cells may provide a novel target for colorectal cancer therapies.
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